Sigma Healthcare Ltd
OTC:SIGGF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
S
|
Sigma Healthcare Ltd
OTC:SIGGF
|
AU |
|
N
|
Nov Inc
DUS:NO8
|
US |
|
Glaukos Corp
NYSE:GKOS
|
US |
|
T
|
Thales SA
F:CSF
|
FR |
|
Bank of Jiangsu Co Ltd
SSE:600919
|
CN |
|
W
|
Wynn Resorts Ltd
XBER:WYR
|
US |
|
Groep Brussel Lambert NV
OTC:GBLBY
|
BE |
Sigma Healthcare Ltd
Sigma Healthcare is an Australian healthcare distribution and pharmacy services company. It supplies prescription medicines, over-the-counter products, and health and beauty items to pharmacies, and it also supports pharmacy brands and operating systems used by independent and banner pharmacies. In simple terms, Sigma sits in the middle of the pharmacy supply chain: it buys products from manufacturers, distributes them to pharmacies, and helps those pharmacies run their businesses more efficiently. Its customers are mainly community pharmacies, pharmacy groups, and healthcare product manufacturers. Sigma makes money by wholesaling medicines and other pharmacy goods, earning a margin on the products it distributes, and by charging for support services and network programs tied to its pharmacy brands and supply arrangements. It also earns value from the scale and frequency of pharmacy replenishment, since pharmacies need regular deliveries of essential products. What makes Sigma’s business model different is that it is not just a distributor or just a retailer. It combines logistics, buying power, and pharmacy support under one roof, which gives it a central role in keeping pharmacies stocked and connected to suppliers. That makes it an important infrastructure business in everyday healthcare, even though the products it handles are familiar and low-profile.
Sigma Healthcare is an Australian healthcare distribution and pharmacy services company. It supplies prescription medicines, over-the-counter products, and health and beauty items to pharmacies, and it also supports pharmacy brands and operating systems used by independent and banner pharmacies. In simple terms, Sigma sits in the middle of the pharmacy supply chain: it buys products from manufacturers, distributes them to pharmacies, and helps those pharmacies run their businesses more efficiently.
Its customers are mainly community pharmacies, pharmacy groups, and healthcare product manufacturers. Sigma makes money by wholesaling medicines and other pharmacy goods, earning a margin on the products it distributes, and by charging for support services and network programs tied to its pharmacy brands and supply arrangements. It also earns value from the scale and frequency of pharmacy replenishment, since pharmacies need regular deliveries of essential products.
What makes Sigma’s business model different is that it is not just a distributor or just a retailer. It combines logistics, buying power, and pharmacy support under one roof, which gives it a central role in keeping pharmacies stocked and connected to suppliers. That makes it an important infrastructure business in everyday healthcare, even though the products it handles are familiar and low-profile.
Chemist Warehouse Loss: Sigma will not be renewing its Chemist Warehouse contract, resulting in a loss of $1.7 billion in annual revenue.
Earnings Impact: Underlying EBIT guidance for the current year has been cut due to weak trading and PBS reforms, now expected to be about $18 million below previous $90 million guidance.
Future Guidance: FY20 underlying EBIT is expected to be between $40 million and $50 million, with only five months of Chemist Warehouse contribution.
Cost-Cutting Plans: Sigma plans to aggressively reduce fixed costs, especially in its distribution center network, to adjust to lower revenues.
Working Capital Release: About $300 million in working capital will be released as Chemist Warehouse business winds down, expected to return by the end of next calendar year.
Revenue Trends: Revenue is expected to be broadly flat for the year, with market weakness and inability to recover increased costs hitting margins.
